XETRA - Delayed Quote EUR
Viatris Inc. (VIA.DE)
7.75
-0.10
(-1.30%)
At close: 5:35:39 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
14,330,200
14,739,300
15,426,900
16,262,700
17,886,300
Cost of Revenue
9,049,400
9,115,700
8,988,300
9,765,700
12,310,800
Gross Profit
5,280,800
5,623,600
6,438,600
6,497,000
5,575,500
Operating Expense
5,187,200
5,234,300
5,455,300
4,841,300
5,210,200
Operating Income
93,600
389,300
983,300
1,655,700
365,300
Net Non Operating Interest Income Expense
-527,100
-550,000
-573,100
-592,400
-636,200
Other Income Expense
-3,491,300
-462,500
-207,300
1,749,900
-393,500
Pretax Income
-3,924,800
-623,200
202,900
2,813,200
-664,400
Tax Provision
-134,700
11,000
148,200
734,600
604,700
Net Income Common Stockholders
-3,790,100
-634,200
54,700
2,078,600
-1,269,100
Diluted NI Available to Com Stockholders
-3,790,100
-634,200
54,700
2,078,600
-1,269,100
Basic EPS
-3.18
-0.53
0.05
1.71
-1.05
Diluted EPS
-3.18
-0.53
0.05
1.71
-1.05
Basic Average Shares
1,192,600
1,193,300
1,200,300
1,212,100
1,208,800
Diluted Average Shares
1,192,600
1,193,300
1,206,900
1,217,400
1,208,800
Total Operating Income as Reported
-3,076,000
10,100
766,200
1,614,900
-34,000
Total Expenses
14,236,600
14,350,000
14,443,600
14,607,000
17,521,000
Net Income from Continuing & Discontinued Operation
-3,790,100
-634,200
54,700
2,078,600
-1,269,100
Normalized Income
-729,281.37
-334,632
226,209
2,108,751.20
-977,611
Interest Expense
527,100
550,000
573,100
592,400
636,200
Net Interest Income
-527,100
-550,000
-573,100
-592,400
-636,200
EBIT
-3,397,700
-73,200
776,000
3,405,600
-28,200
EBITDA
-530,800
2,820,000
3,516,500
6,433,200
4,478,300
Reconciled Cost of Revenue
9,049,400
9,115,700
8,988,300
9,765,700
12,310,800
Reconciled Depreciation
2,866,900
2,893,200
2,740,500
3,027,600
4,506,500
Net Income from Continuing Operation Net Minority Interest
-3,790,100
-634,200
54,700
2,078,600
-1,269,100
Total Unusual Items Excluding Goodwill
-3,169,600
-379,200
-217,100
-40,800
-399,300
Total Unusual Items
-3,169,600
-379,200
-217,100
-40,800
-399,300
Normalized EBITDA
2,638,800
3,199,200
3,733,600
6,474,000
4,877,600
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-108,781.37
-79,632
-45,591
-10,648.80
-107,811
12/31/2021 - 12/13/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
27N0.DE CANNOVUM CANNABIS AG I
0.2250
0.00%
ZOE.DE Zoetis Inc.
141.92
-1.06%
B8FK.DE Biofrontera AG
2.4300
0.00%
H6D0.DE Haleon plc
4.6390
-1.44%
BXT.DE BioNxt Solutions Inc.
0.3550
-3.01%
SBX.DE SynBiotic SE
3.1650
0.00%
APPH.DE Apontis Pharma AG
10.90
+0.93%
PSG.DE PharmaSGP Holding SE
28.60
-0.69%
HIGH.DE Cantourage Group SE
6.50
-0.61%
DMP.DE Dermapharm Holding SE
35.70
+1.13%